124 related articles for article (PubMed ID: 12830492)
1. [The role of Matrix Metaloproteinases in the progression of periodontitis, and the use of specific inhibitors to these enzymes in the treatment of the periodontal disease].
Nasatzky E; Rubinstein Y; Goultschin J; Schwartz Z
Refuat Hapeh Vehashinayim (1993); 2003 Apr; 20(2):38-45, 81. PubMed ID: 12830492
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid laminin-5 gamma2 chain levels in chronic periodontitis.
Emingil G; Atilla G; Sorsa T; Savolainen P; Baylas H
J Periodontol; 2004 Oct; 75(10):1387-96. PubMed ID: 15562917
[TBL] [Abstract][Full Text] [Related]
3. The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis.
Emingil G; Atilla G; Sorsa T; Luoto H; Kirilmaz L; Baylas H
J Periodontol; 2004 Jan; 75(1):106-15. PubMed ID: 15025222
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of periodontitis: role of cytokines in host response.
Deo V; Bhongade ML
Dent Today; 2010 Sep; 29(9):60-2, 64-6; quiz 68-9. PubMed ID: 20973418
[TBL] [Abstract][Full Text] [Related]
5. Effect of locally delivered minocycline microspheres on markers of bone resorption.
Oringer RJ; Al-Shammari KF; Aldredge WA; Iacono VJ; Eber RM; Wang HL; Berwald B; Nejat R; Giannobile WV
J Periodontol; 2002 Aug; 73(8):835-42. PubMed ID: 12211491
[TBL] [Abstract][Full Text] [Related]
6. Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD).
Caton J; Ryan ME
Pharmacol Res; 2011 Feb; 63(2):114-20. PubMed ID: 21182947
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
Buduneli E; Vardar-Sengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
J Periodontol; 2007 Jan; 78(1):127-34. PubMed ID: 17199549
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
Gürkan A; Cinarcik S; Hüseyinov A
J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
[TBL] [Abstract][Full Text] [Related]
9. The effect of adjunctive subantimicrobial dose doxycycline therapy on GCF EMMPRIN levels in chronic periodontitis.
Emingil G; Atilla G; Sorsa T; Tervahartiala T
J Periodontol; 2008 Mar; 79(3):469-76. PubMed ID: 18315429
[TBL] [Abstract][Full Text] [Related]
10. The effect of subgingival antimicrobial therapy on the levels of stromelysin and tissue inhibitor of metalloproteinases in gingival crevicular fluid.
Pourtaghi N; Radvar M; Mooney J; Kinane DF
J Periodontol; 1996 Sep; 67(9):866-70. PubMed ID: 8884643
[TBL] [Abstract][Full Text] [Related]
11. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.
Lee HM; Ciancio SG; Tüter G; Ryan ME; Komaroff E; Golub LM
J Periodontol; 2004 Mar; 75(3):453-63. PubMed ID: 15088884
[TBL] [Abstract][Full Text] [Related]
12. Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review.
Preshaw PM; Hefti AF; Jepsen S; Etienne D; Walker C; Bradshaw MH
J Clin Periodontol; 2004 Sep; 31(9):697-707. PubMed ID: 15312090
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
[TBL] [Abstract][Full Text] [Related]
14. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Periostat for patient management.
Caton JG
Compend Contin Educ Dent; 1999 May; 20(5):451-6, 458-60, 462; quiz 463. PubMed ID: 10650360
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis.
Novak MJ; Johns LP; Miller RC; Bradshaw MH
J Periodontol; 2002 Jul; 73(7):762-9. PubMed ID: 12146536
[TBL] [Abstract][Full Text] [Related]
17. Gingival crevicular fluid matrix metalloproteinase-25 and -26 levels in periodontal disease.
Emingil G; Kuula H; Sorsa T; Atilla G
J Periodontol; 2006 Apr; 77(4):664-71. PubMed ID: 16584348
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation.
Sorsa T; Tjäderhane L; Konttinen YT; Lauhio A; Salo T; Lee HM; Golub LM; Brown DL; Mäntylä P
Ann Med; 2006; 38(5):306-21. PubMed ID: 16938801
[TBL] [Abstract][Full Text] [Related]
19. Minocycline microspheres: a complementary medical-mechanical model for the treatment of chronic periodontitis.
Paquette DW
Compend Contin Educ Dent; 2002 May; 23(5 Suppl):15-21. PubMed ID: 12789964
[TBL] [Abstract][Full Text] [Related]
20. The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis.
Górska R; Nedzi-Góra M
Arch Immunol Ther Exp (Warsz); 2006; 54(6):419-26. PubMed ID: 17122880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
